Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: The role of stress and of antipsychotic treatment

Agid, 2006, The “delayed onset” of antipsychotic action—an idea whose time has come and gone, J. Psychiatry Neurosci., 31, 93 Barkus, 2006, Cannabis-induced psychosis-like experiences are associated with high schizotypy, Psychopathology, 39, 175, 10.1159/000092678 Bebbington, 1995, The psychosis screening questionnaire, Int. J. Methods Psychiatr. Res., 5, 11 Bebbington, 1993, Life events and psychosis. Initial results from the Camberwell Collaborative Psychosis Study, Br. J. Psychiatry., 162, 72, 10.1192/bjp.162.1.72 Bhagwagar, 2003, Increase in concentration of waking salivary cortisol in recovered patients with depression, Am. J. Psychiatry., 160, 1890, 10.1176/appi.ajp.160.10.1890 Bhagwagar, 2005, Increased salivary cortisol after waking in depression, Psychopharmacology (Berl)., 1 Bifulco, 2005, The childhood experience of care and abuse questionnaire (CECA.Q): validation in a community series, Br. J. Clin. Psychol., 44, 563, 10.1348/014466505X35344 Breier, 1988, Neurobiological effects of lumbar puncture stress in psychiatric patients and healthy volunteers, Psychiatry Res., 25, 187, 10.1016/0165-1781(88)90050-9 Broome, 2005, What causes the onset of psychosis?, Schizophr. Res., 79, 23, 10.1016/j.schres.2005.02.007 Brugha, 1990, The List of Threatening Experiences: the reliability and validity of a brief life events questionnaire, Acta Psychiatr. Scand., 82, 77, 10.1111/j.1600-0447.1990.tb01360.x Ceskova, 2006, Dexamethasone suppression test in first-episode schizophrenia, Neuro. Endocrinol. Lett., 27, 433 Cleare, 2003, The neuroendocrinology of chronic fatigue syndrome, Endocr. Rev., 24, 236, 10.1210/er.2002-0014 Clow, 2004, The awakening cortisol response: methodological issues and significance, Stress, 7, 29, 10.1080/10253890410001667205 Cohen, 1988, Perceived stress in a probability sample of the United Stated Cohrs, 2006, The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects, Psychopharmacology (Berl)., 185, 11, 10.1007/s00213-005-0279-x Compton, 2004, Preliminary evidence of an association between childhood abuse and cannabis dependence among African American first-episode schizophrenia-spectrum disorder patients, Drug Alcohol Depend., 76, 311, 10.1016/j.drugalcdep.2004.05.005 De Leon, 2005, A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors, Schizophr. Res., 76, 135, 10.1016/j.schres.2005.02.010 Debattista, 2006, The use of mifepristone in the treatment of neuropsychiatric disorders, Trends Endocrinol. Metab., 17, 117, 10.1016/j.tem.2006.02.006 Di Forti, 2007, Cannabis use and psychiatric and cogitive disorders: the chicken or the egg?, Curr. Opin. Psychiatry, 20, 228, 10.1097/YCO.0b013e3280fa838e Dinan, 2005, Stress: the shared common component in major mental illnesses, Eur. Psychiatry, 20, S326, 10.1016/S0924-9338(05)80184-1 D'Souza, 2004, The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis, Neuropsychopharmacology, 29, 1558, 10.1038/sj.npp.1300496 D'Souza, 2005, Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction, Biol. Psychiatry, 57, 594, 10.1016/j.biopsych.2004.12.006 Fearon, 2006, Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study, Psychol. Med., 36, 1541, 10.1017/S0033291706008774 Fisher, 2009, Gender differences in the association between childhood abuse and psychosis, Br. J. Psychiatry, 194, 319, 10.1192/bjp.bp.107.047985 Flores, 2006, Clinical and biological effects of mifepristone treatment for psychotic depression, Neuropsychopharmacology, 31, 628, 10.1038/sj.npp.1300884 Gallagher, 2007, Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder, Schizophr. Res., 90, 258, 10.1016/j.schres.2006.11.020 Garner, 2005, Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis, Biol. Psychiatry., 58, 417, 10.1016/j.biopsych.2005.04.018 Gunduz-Bruce, 2007, Cortisol levels in relation to hippocampal sub-regions in subjects with first episode schizophrenia, Schizophr. Res., 94, 281, 10.1016/j.schres.2007.03.025 Hatzimanolis, 1998, Neurochemical variables in schizophrenic patients during switching from neuroleptics to clozapine, Prog. Neuropsychopharmacol. Biol. Psychiatry, 22, 1077, 10.1016/S0278-5846(98)00064-5 Heim, 2000, Pituitary–adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood, JAMA, 284, 592, 10.1001/jama.284.5.592 Herz, 1985, The dexamethasone suppression test in newly hospitalized schizophrenic patients, Am. J. Psychiatry, 142, 127, 10.1176/ajp.142.1.127 Iancu, 2007, Circulatory neurosteroid levels in smoking and non-smoking chronic schizophrenia patients, Eur. Neuropsychopharmacol., 17, 541, 10.1016/j.euroneuro.2007.02.001 Ismail, 1998, The dexamethasone suppression test in schizophrenia, Psychol. Med., 28, 311, 10.1017/S0033291797006521 Jakovljevic, 2007, The effects of olanzapine and fluphenazine on plasma cortisol, prolactin and muscle rigidity in schizophrenic patients: a double blind study, Prog. Neuropsychopharmacol. Biol. Psychiatry, 31, 399, 10.1016/j.pnpbp.2006.10.007 Jansen, 1998, Blunted cortisol response to a psychosocial stressor in schizophrenia, Schizophr. Res., 33, 87, 10.1016/S0920-9964(98)00066-8 Jansen, 2000, Selective impairments in the stress response in schizophrenic patients, Psychopharmacology (Berl)., 149, 319, 10.1007/s002130000381 Juruena, 2006, Different responses to dexamethasone and prednisolone in the same depressed patients, Psychopharmacology (Berl)., 189, 225, 10.1007/s00213-006-0555-4 Kirkbride, 2006, Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study, Arch. Gen. Psychiatry, 63, 250, 10.1001/archpsyc.63.3.250 Lammers, 1995, Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II, Biol. Psychiatry, 38, 803, 10.1016/0006-3223(95)00065-8 Mallett, 2002, Social environment, ethnicity and schizophrenia. A case–control study, Soc. Psychiatry Psychiatr. Epidemiol., 37, 329, 10.1007/s00127-002-0557-4 Maninger, 2009, Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS), Front Neuroendocrinol., 30, 65, 10.1016/j.yfrne.2008.11.002 Mann, 2006, Nocturnal hormone profiles in patients with schizophrenia treated with olanzapine, Psychoneuroendocrinology, 31, 256, 10.1016/j.psyneuen.2005.08.005 Markianos, 1999, Switch from neuroleptics to clozapine does not influence pituitary–gonadal axis hormone levels in male schizophrenic patients, Eur. Neuropsychopharmacol., 9, 533, 10.1016/S0924-977X(99)00040-1 McGuffin, 1991, A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system, Arch. Gen. Psychiatry, 48, 764, 10.1001/archpsyc.1991.01810320088015 Meltzer, 1989, Clinical studies on the mechanism of action of clozapine: the dopamine–serotonin hypothesis of schizophrenia, Psychopharmacology (Berl)., 99, S18, 10.1007/BF00442554 Mondelli, 2008, Pituitary volume in unaffected relatives of patients with schizophrenia and bipolar disorder, Psychoneuroendocrinology, 33, 1004, 10.1016/j.psyneuen.2008.05.010 Morgan, 2006, Clinical and social determinants of duration of untreated psychosis in the AESOP first-episode psychosis study, Br. J. Psychiatry, 189, 446, 10.1192/bjp.bp.106.021303 Myin-Germeys, 2007, Stress-reactivity in psychosis: evidence for an affective pathway to psychosis, Clin. Psychol. Rev., 27, 409, 10.1016/j.cpr.2006.09.005 Myin-Germeys, 2001, Emotional reactivity to daily life stress in psychosis, Arch. Gen. Psychiatry, 58, 1137, 10.1001/archpsyc.58.12.1137 Nemeroff, 2004, Neurobiological consequences of childhood trauma, J. Clin. Psychiatry, 65, 18 Oquendo, 2003, Lower cortisol levels in depressed patients with comorbid post-traumatic stress disorder, Neuropsychopharmacology, 28, 591, 10.1038/sj.npp.1300050 Pariante, 2008, Pituitary volume in psychosis: the first review of the evidence, J. Psychopharmacol., 22, 76, 10.1177/0269881107084020 Pariante, 2008, The HPA axis in major depression: classical theories and new developments, Trends Neurosci., 31, 464, 10.1016/j.tins.2008.06.006 Pariante, 2004, Pituitary volume in psychosis, Br. J. Psychiatry, 185, 5, 10.1192/bjp.185.1.5 Pariante, 2005, Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study, Neuropsychopharmacology, 30, 1923, 10.1038/sj.npp.1300766 Popovic, 2007, Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia, Neuroendocrinology, 85, 249, 10.1159/000103868 Pruessner, 2003, Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change, Psychoneuroendocrinology, 28, 916, 10.1016/S0306-4530(02)00108-7 Pruessner, 2008, Sex differences in the cortisol response to awakening in recent onset psychosis, Psychoneuroendocrinology, 33, 1151, 10.1016/j.psyneuen.2008.04.006 Read, 2005, Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications, Acta Psychiatr. Scand., 112, 330, 10.1111/j.1600-0447.2005.00634.x Roberts, 2004, Salivary cortisol response to awakening in chronic fatigue syndrome, Br. J. Psychiatry, 184, 136, 10.1192/bjp.184.2.136 Rohleder, 2006, The hypothalamic–pituitary–adrenal (HPA) axis in habitual smokers, Int. J. Psychophysiol, 59, 236, 10.1016/j.ijpsycho.2005.10.012 Rohleder, 2004, Hypocortisolism and increased glucocorticoid sensitivity of pro-inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder, Biol. Psychiatry, 55, 745, 10.1016/j.biopsych.2003.11.018 Ryan, 2003, Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia, Am. J. Psychiatry, 160, 284, 10.1176/appi.ajp.160.2.284 Ryan, 2004, Evidence of basal pituitary–adrenal overactivity in first episode, drug naive patients with schizophrenia, Psychoneuroendocrinology, 29, 1065, 10.1016/j.psyneuen.2003.08.011 Sachar, 1970, Psychoendocrinology of ego disintegration, Am. J. Psychiatry, 126, 1067, 10.1176/ajp.126.8.1067 Schatzberg, 2008, Glucocorticoid antagonists in neuropsychotic disorders, Eur. J. Pharmacol, 583, 358, 10.1016/j.ejphar.2008.01.001 Scheepers, 2001, The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia, J. Clin. Psychopharmacol, 21, 575, 10.1097/00004714-200112000-00006 Strous, 2004, Increased circulatory dehydroepiandrosterone and dehydroepiandrosterone-sulphate in first-episode schizophrenia: relationship to gender, aggression and symptomatology, Schizophr. Res., 71, 427, 10.1016/j.schres.2004.03.005 Tandon, 1991, Dexamethasone suppression test in schizophrenia: relationship to symptomatology, ventricular enlargement, and outcome, Biol. Psychiatry, 29, 953, 10.1016/0006-3223(91)90353-N Walker, 1997, Schizophrenia: a neural diathesis-stress model, Psychol. Rev., 104, 667, 10.1037/0033-295X.104.4.667 Walker, 2008, Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia, Annu. Rev. Clin. Psychol., 4, 189, 10.1146/annurev.clinpsy.4.022007.141248 Wessa, 2006, Altered cortisol awakening response in posttraumatic stress disorder, Psychoneuroendocrinology, 31, 209, 10.1016/j.psyneuen.2005.06.010 Wing, 1978 1992 Yehuda, 2001, Biology of posttraumatic stress disorder, J. Clin. Psychiatry, 62, 41 Zhang, 2005, Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics, Neuropsychopharmacology, 30, 1532, 10.1038/sj.npp.1300756